These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27251172)

  • 1. Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes.
    Radreau P; Porcherot M; Ramière C; Mouzannar K; Lotteau V; André P
    FASEB J; 2016 Sep; 30(9):3146-54. PubMed ID: 27251172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor-α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo.
    Mouzannar K; Fusil F; Lacombe B; Ollivier A; Ménard C; Lotteau V; Cosset FL; Ramière C; André P
    FASEB J; 2019 Feb; 33(2):2472-2483. PubMed ID: 30307769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
    J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
    Ito K; Okumura A; Takeuchi JS; Watashi K; Inoue R; Yamauchi T; Sakamoto K; Yamashita Y; Iguchi Y; Une M; Wakita T; Umezawa K; Yoneda M
    Hepatology; 2021 Jul; 74(1):83-98. PubMed ID: 33434356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid-microbiota crosstalk in hepatitis B virus infection.
    Wang J; Xu H; Liu Z; Cao Y; Chen S; Hou R; Zhou Y; Wang Y
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1509-1516. PubMed ID: 38721685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
    Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
    Ni Y; Urban S
    Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
    Zhao K; Liu S; Chen Y; Yao Y; Zhou M; Yuan Y; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Zhao H; Lu M; Wu C; Chen X
    Emerg Microbes Infect; 2018 Nov; 7(1):186. PubMed ID: 30459339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
    Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
    Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA.
    Nkongolo S; Nußbaum L; Lempp FA; Wodrich H; Urban S; Ni Y
    Antiviral Res; 2019 Aug; 168():146-155. PubMed ID: 31018112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
    Legrand AF; Lucifora J; Lacombe B; Ménard C; Michelet M; Foca A; Abrial P; Salvetti A; Rivoire M; Lotteau V; Durantel D; André P; Ramière C
    Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37058078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.
    Sissung TM; Huang PA; Hauke RJ; McCrea EM; Peer CJ; Barbier RH; Strope JD; Ley AM; Zhang M; Hong JA; Venzon D; Jackson JP; Brouwer KR; Grohar P; Glod J; Widemann BC; Heller T; Schrump DS; Figg WD
    Mol Pharmacol; 2019 Aug; 96(2):158-167. PubMed ID: 31175181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
    Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
    Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
    Allweiss L; Volz T; Giersch K; Kah J; Raffa G; Petersen J; Lohse AW; Beninati C; Pollicino T; Urban S; Lütgehetmann M; Dandri M
    Gut; 2018 Mar; 67(3):542-552. PubMed ID: 28428345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.